Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Change in Account Payables: 2020-2022

Historic Change in Account Payables for Beauty Health (SKIN) over the last 2 years, with Dec 2022 value amounting to -$7.3 million.

  • Beauty Health's Change in Account Payables fell 139.42% to -$7.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$262,000, marking a year-over-year decrease of 102.49%. This contributed to the annual value of $15.8 million for FY2023, which is 6124.05% up from last year.
  • According to the latest figures from Q4 2022, Beauty Health's Change in Account Payables is -$7.3 million, which was down 1,088.47% from -$616,000 recorded in Q3 2022.
  • Beauty Health's 5-year Change in Account Payables high stood at $18.6 million for Q4 2021, and its period low was -$7.3 million during Q4 2022.
  • Moreover, its 3-year median value for Change in Account Payables was -$1.6 million (2022), whereas its average is $1.3 million.
  • Within the past 5 years, the most significant YoY rise in Beauty Health's Change in Account Payables was 290.19% (2022), while the steepest drop was 186.86% (2022).
  • Beauty Health's Change in Account Payables (Quarterly) stood at $6.3 million in 2020, then spiked by 195.39% to $18.6 million in 2021, then plummeted by 139.42% to -$7.3 million in 2022.
  • Its Change in Account Payables stands at -$7.3 million for Q4 2022, versus -$616,000 for Q3 2022 and $10.3 million for Q2 2022.